M
Medical Concierge Centrum Medyczne | Warsaw, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Guselkumab
Orforglipron
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.
Active, not recruiting
Crohn Disease
Drug: Guselkumab Dose 3
Drug: Placebo
Locations recently updated
The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...
Not yet enrolling
Urinary Incontinence,Stress
Drug: Placebo
Drug: Orforglipron
Researchers are looking for new ways to treat high-risk non muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the i...
Active, not recruiting
High-risk Non-muscle Invasive Bladder Cancer
Biological: Pembrolizumab
Biological: BCG
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems